Visikol

Visikol

Biotechnology Research

Hampton, New Jersey 5,725 followers

Advanced imaging, digital pathology and 3D cell culture drug discovery services.

About us

Visikol is a contract research services company that is focused on accelerating the drug discovery and development process through providing its clients with advanced tissue imaging and advanced cell culture services. Today, Visikol counts all twenty of the top twenty pharmaceutical companies as clients and has been instrumental in dozens of drug discovery programs. The company provides end-to-end services that include 3D tissue imaging, multiplex tissue imaging, digital pathology, high content imaging, 2D cell culture assays, 3D cell culture assays and ex vivo tissue slice assays. Visikol’s expertise lies in both transforming tissues into actionable insights as well as bridging the gap between in vitro assays and in vivo results through the use of best-in-class cell culture models. In addition to its services, Visikol sells a suite of tissue clearing reagents and kits as well as the HUREL® Micro Liver portfolio of primary hepatocyte liver models.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Hampton, New Jersey
Type
Privately Held
Founded
2016
Specialties
drug discovery, high throughput screening, high content screening, whole mount imaging, 3D cell cultures, in vitro assays, confocal microscopy, antibody penetration, organoids, and digital pathology

Locations

  • Primary

    53 Frontage Road

    Shelbourne Building, Suite #120

    Hampton, New Jersey 08827, US

    Get directions

Employees at Visikol

Updates

Similar pages

Browse jobs

Funding

Visikol 9 total rounds

Last Round

Grant

US$ 1.6M

See more info on crunchbase